IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SINAGRA, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.463
AS - Asia 1.878
EU - Europa 980
SA - Sud America 393
AF - Africa 48
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.769
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.372
SG - Singapore 670
CN - Cina 480
BR - Brasile 336
HK - Hong Kong 260
IT - Italia 243
DE - Germania 162
VN - Vietnam 135
BD - Bangladesh 109
FI - Finlandia 108
FR - Francia 84
GB - Regno Unito 76
RU - Federazione Russa 76
UA - Ucraina 76
TR - Turchia 63
IN - India 56
CA - Canada 54
IE - Irlanda 36
JP - Giappone 24
MX - Messico 23
PL - Polonia 21
ZA - Sudafrica 17
IQ - Iraq 16
AR - Argentina 15
SE - Svezia 15
ES - Italia 14
AT - Austria 13
NL - Olanda 13
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
MA - Marocco 10
EC - Ecuador 8
LT - Lituania 8
KE - Kenya 7
PK - Pakistan 7
CL - Cile 6
CO - Colombia 6
PY - Paraguay 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
AZ - Azerbaigian 4
BE - Belgio 4
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
PH - Filippine 4
EG - Egitto 3
ID - Indonesia 3
JM - Giamaica 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
SC - Seychelles 3
TN - Tunisia 3
AM - Armenia 2
CR - Costa Rica 2
GR - Grecia 2
IL - Israele 2
NP - Nepal 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 5.769
Salva come PNG Salva come JPEG
Città #
Ashburn 342
Singapore 330
Hong Kong 259
San Jose 229
Beijing 148
The Dalles 116
Fairfield 111
New York 107
Los Angeles 87
Helsinki 78
Dallas 70
Woodbridge 66
Chandler 57
Jacksonville 56
Lauterbourg 56
Munich 55
Seattle 55
Istanbul 54
Ho Chi Minh City 52
Wilmington 44
Houston 41
Princeton 40
São Paulo 39
Cambridge 37
Dublin 36
Buffalo 34
Milan 33
Hanoi 31
Orem 31
Romola 27
Redondo Beach 26
Ann Arbor 25
Shanghai 25
San Francisco 24
Montreal 23
Moscow 23
Chennai 21
Chicago 20
Tokyo 20
Santa Clara 19
Washington 19
Brescia 18
Turku 18
Warsaw 18
Frankfurt am Main 17
Rome 17
Council Bluffs 16
Nanjing 16
London 15
Guangzhou 14
Nuremberg 14
Atlanta 13
Boston 13
Toronto 13
Brooklyn 12
Poplar 12
Denver 11
Des Moines 11
Dearborn 10
Hangzhou 10
Johannesburg 10
Lappeenranta 10
Stockholm 10
Belo Horizonte 9
Brno 9
City of London 9
Brasília 8
Dhaka 8
Haiphong 8
Hebei 8
Rio de Janeiro 8
San Diego 8
Vienna 8
Amsterdam 7
Boydton 7
Düsseldorf 7
Naples 7
Phoenix 7
Salvador 7
Ankara 6
Curitiba 6
Da Nang 6
Mumbai 6
Novara 6
Paris 6
Querétaro 6
Baghdad 5
Charlotte 5
Hải Dương 5
Jinan 5
Lahore 5
Manchester 5
Mexico City 5
Nairobi 5
Pune 5
Salt Lake City 5
Sete Lagoas 5
Shenyang 5
Tashkent 5
Trieste 5
Totale 3.501
Salva come PNG Salva come JPEG
Nome #
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 160
Heart failure and anemia: Effects on prognostic variables 151
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 146
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 145
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 144
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 133
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 130
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 120
ANMCO / FADOI / SIAARTI / SIC / SIMG / SIMI / SIMEU Consensus Document: The clinical-diagnostic and therapeutic pathway of the patient with acute heart failure from home to discharge from the Emergency Room / Emergency Department-Acceptance 120
The prognostic value of serial troponin measurements in patients admitted for COVID-19 116
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 111
The chronic heart failure evolutions: Different fates and routes 109
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 106
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 106
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 106
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 106
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 101
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 100
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 98
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice] 97
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 97
[Palliative inotrope therapy in advanced heart failure: organization and management] 97
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 95
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 92
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 92
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 90
[2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology] 89
[Transcatheter devices for chronic heart failure: state of the art] 88
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 86
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 86
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 85
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 85
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology] 84
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 83
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 83
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 83
[Italian Society of Cardiology (SIC) Position paper: Technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine] 82
Impact of malnutrition in patients with severe heart failure 81
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 81
Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring trasmissions 80
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 77
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 76
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 75
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 73
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 71
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 71
[Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection] 69
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 66
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 64
Palliative care in the cardiac setting: A consensus document of the Italian Society of Cardiology (SIC) and Italian Society of Palliative Care (SICP) Joint Working Group 64
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 63
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 63
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 62
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry 62
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 60
Management of hypertrophic cardiomyopathy 60
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 60
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 58
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 58
Effects of the COVID-19 pandemic on the formation of fellows in training in cardiology 55
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 55
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 52
Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study 51
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 48
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 47
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 46
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 44
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology 42
Totale 5.836
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022123 6 5 5 9 1 5 1 9 7 16 19 40
2022/2023238 37 23 4 4 11 52 2 23 51 3 14 14
2023/2024637 35 13 68 60 43 111 39 23 111 25 26 83
2024/20251.317 15 12 43 144 97 100 173 69 120 91 248 205
2025/20262.905 270 387 205 390 341 213 337 127 195 195 182 63
Totale 5.836